Pharmaceutical

Pneumatic Nebulizers Market Showing 6% CAGR Growth to 2023: Company Profiles & Growth Analysis

Posted on Updated on

The newly released research at Market Study Report titled “2016-2023 Global Pneumatic Nebulizers Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years.

Pneumatic Nebulizers Market size is estimated to reach USD 1.05 billion by 2023; as per a new research report.  Prevalence of allergic diseases and asthma has increased dramatically over the years, mainly due to urbanization, and increasing number of motor vehicles causing high levels of air pollution.

According to the American Lung Association, over than 10 million people in the U.S. suffered from chronic bronchitis in 2011, while 4.7 million people had emphysema, and 24 million adults were diagnosed with COPD. The Global Burden of Diseases Study estimates the total number of asthma patients to be 334 million worldwide. With such high prevalence of respiratory disorders along with a projected increase in the coming years, pneumatic nebulizers market size is set to witness a healthy growth trajectory.

The economic burden and productivity loss associated with respiratory disorders is of growing concern to the governments globally. Citing this, various associations have come forth with recommendations to manage these diseases. Recommendations such as inclusion of asthma medicines on all national lists of essential medicines, as well as under reimbursed medicines, and implementation of effective policy actions on causes of asthma such as smoking and occupational exposures have been presented. The presence of a favorable regulatory landscape will drive the global pneumatic nebulizers market.

Growing popularity for home care settings, especially among the elderly patients has also fueled growth. Both the vented and breath-actuated portable nebulizers market is set to outpace the table-top segment in the years to come. These products are expected to register the highest CAGR of 7.5% throughout the forecast period attributed to the rising need for convenience, and portability.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467758/

Key insights from the report include:

Global pneumatic nebulizers market generated revenue of USD 626.2 million in 2015, and is anticipated to reach USD 1.05 billion by 2023, projected to grow at a CAGR of 6.8% from 2016 to 2023. Global industry volume is forecast to reach approximately 11 million units by 2023.

Increased awareness regarding respiratory disorders and availability of technologically advanced products has boosted demand in North America.

Germany and the UK served as the major revenue contributors for Europe pneumatic nebulizers market share, contributing over 50% revenue in 2015.

The industry is highly competitive, key players compete on the basis of manufacturers’ ability to respond quickly to changing preferences, and pricing owing to large presence of local manufacturers. Major companies are Omron Corporation, Becton, Dickinson and Company, Philips Respironics, Salter Labs, DeVilbiss Healthcare, etc.

Asia Pacific pneumatic nebulizers market growth is hinged on China, India, and Japan. China is the fastest growing regional industry witnessing a CAGR of 9.1% during the forecast period, followed by India, and Japan, while LATAM growth was driven by Mexico and Brazil.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467758/

Selected points from Table of Contents of this report:

Chapter 1.    Methodology and Scope

1.1.    Research Methodology

1.1.1.    Initial data exploration

1.1.2.    Statistical modeling and forecast

1.1.3.    Industry insights and validation

1.2.        Data Sources

Chapter 2.    Executive Summary

2.1.    Pneumatic Nebulizers industry 360 degree synopsis, 2012 – 2023

2.1.1.    Business trends

2.1.2.    Regional trends

2.1.3.    Product trends

Chapter 3.    Pneumatic Nebulizers Industry Insights

3.1.    Industry segmentation

3.2.    Industry Size and forecast, 2012 – 2023

3.3.    Industry Impact forces

3.3.1.    Growth drivers

3.3.1.1. Rising prevalence of respiratory disorders

3.3.1.2. Increasing geriatric population

3.3.1.3. Growing pollution levels

3.3.1.4. Technological advancements

3.3.2.    Industry pitfalls & challenges

3.3.2.1. Lack of awareness regarding respiratory diseases and its treatment

3.3.2.2 Complexities in devices

3.4.    Growth potential analysis

3.4.1 Emerging countries

3.4.2 Growth in point of care (PoC) diagnostics market

3.5.    Porter’s analysis

3.6.    PESTEL analysis

Chapter 4.    Pneumatic Nebulizers Product Insights

4.1.    Pneumatic nebulizers market share by product, 2015 & 2023

4.2.    Vented Pneumatic Nebulizers

4.2.1.    Tabletop vented pneumatic nebulizers

4.2.1.1.    Market estimates and forecasts by region, 2012 – 2023

4.2.2.    Portable vented pneumatic nebulizers

For More Info: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Web site: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog/

Animal Healthcare Market Forthcoming Developments, Growth Challenges, Opportunities 2024

Posted on Updated on

The Animal Healthcare market dynamics, forces, companies and trends have been determined after conducting a detailed study of the industry for this newly released research report now available with Market Study Report.

Animal Healthcare Market size to exceed USD 36 billion by 2024, as per a new research report.

Increasing prevalence of animal diseases coupled with growing adoption of pet animals should drive the global animal healthcare market size. Rising disposable income of pet owners especially in developed regions will enable them to spend on pet healthcare leading to exponential animal healthcare market growth.

Increasing demand for animal source protein and animal healthcare products will escalate over the forecast years. With global population expanding at an alarming rate, the demand for animal source protein and animal healthcare products will only increase, resulting to more animal farming over the forecast timeframe.

Favorable government initiatives to promote animal healthcare practices and rapid developments in the field of animal health medicine will serve as a high impact rendering factor over the forecast years.

Stringent regulations in many countries pertaining to use of antibiotics and antimicrobials in animal feed, high cost associated with animal testing and low out-of-pocket pet healthcare expenditure in developing countries will restrain the market growth over the coming years.

Animal parasiticides should witness high growth over the coming years owing to rising awareness about parasites and their ill-effects on animal and human health. Increasing use of parasiticides in growing number of farm and companion animals should drive the business growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/496334/

U.S. animal healthcare market held largest regional market share in 2016, owing to rising number of pet animals, high disposable incomes of pet owners, escalated awareness about animal health, availability of advanced medicines and presence of large number of established companies. Advancements in animal pharmaceuticals, biologicals and personalized pet medicines should continue to fuel the industry growth.

France animal healthcare market held largest regional share in 2016. Increasing demand for anti-infectives and endoparacitisides for prevention of zoonotic diseases should stimulate business growth. Growing use of animal derived pharmaceutical proteins will spur industry growth.

Some of the leading industry players include Zoetis, Merck, Elanco, Bayer, Boehringer Ingelheim, Virbac, Phirbo Animal Health, Ceva Sante Animale, and Vetoquinol. Merger and acquisition, new product development and geographical expansion are some of the strategies adopted by industry participants to gain market share.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/496334/

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.1.1.  Initial data exploration

1.1.2.   Statistical model and forecast

1.1.3.   Industry insights and validation

1.1.4.   Market definition & forecast parameters

1.2. Data sources

1.2.1.  Secondary

1.2.2.   Primary

Chapter 2. Executive Summary

2.1. Animal healthcare market 3600 synopsis, 2013 –2024

2.1.1.  Business trends

2.1.2.   Pharmaceutical type trends

2.1.3.   Vaccine trends

2.1.4.   Medicinal feed additives trends

2.1.5.   Animal type trends

2.1.6.   Regional trends

Chapter 3. Animal Healthcare Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Growing trend of adopting pet animals

3.3.1.2.      Rising prevalence of food borne and zoonotic diseases

3.3.1.3.      Favorable government initiatives

3.3.1.4.      Rapidly increasing demand for animal protein in human food

3.3.1.5.      Technological advancement in development of animal health drugs

3.3.2.  Industry pitfalls & challenges

3.3.2.1.  Regulations of antibiotics

3.3.2.2.      Prohibitive cost associated with animal tests

3.3.2.3.      Low out of pocket expenditure on pet healthcare in developing countries

3.4. Regulatory landscape

3.4.1.  U.S.

3.4.2.   Europe

3.4.3.   Asia Pacific

For More Info: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Web site: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog/

Global Pet Cancer Therapeutics Market Forecast Showing 10% CAGR to 2024

Posted on Updated on

The newly released research at Market Study Report titled “2017-2024 Global Pet Cancer Therapeutics Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years.

Pet Cancer Therapeutics Market size to exceed USD 300 million by 2024, as per a new research report.

Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics market growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years.

High cost of pet cancer drugs along with rising instances of adverse drug events should hamper industry growth over the forecast years. Lack of awareness regarding pet diseases among the pet owners will impede industry expansion

Chemotherapy has been the mainstream medication for pet cancers till recent times. However, immunological vaccines entered the market and are gaining significant market share. With number of chemotherapy drugs in pipeline, the industry should witness considerable growth over the coming years.

Dogs are more prone to develop cancer than cats and the healthy pipeline will drive segment growth over the forecast years. However, introduction of specialized cat cancer medicines will stimulate the cat cancer therapeutics market growth.

Pet healthcare companies are focusing on development of drugs for mast cell cancer and melanoma among other cancer types. This trend will witness change as medicines to treat lymphoma and mammary cell cancer are in the pipeline. Innovative medicines for treatment of multiple cancer tumors is anticipated to accelerate business growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/568794/

U.S. pet cancer therapeutics market holds the largest revenue share in 2016. Presence of large number of pet drug manufacturing companies, quick adoption of innovative pet care medicines and increasing disposable income of pet owners will boost industry growth.

Australia pet cancer therapeutics market held highest regional revenue share in 2016 owing to growing pet-keeping trend, availability of innovative pet care medicines and increasing disposable income of pet owners.

Some of the leading industry players include Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus, CanFel Therapeutics, Karyopharms Verdinexor. The most commonly adopted business strategies by industry participants includes new product launches, regional expansion and mergers and acquisition.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/568794/

Table of Content:

Chapter 1.    Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition & forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2.    Executive Summary

2.1. Pet cancer therapeutics market 360 degree synopsis, 2013 -2024

2.1.1. Business trends

2.1.2. Medicine type trends

2.1.3. Species trends

2.1.4. Cancer type trends

2.1.5. Regional trends

Chapter 3.    Pet cancer therapeutics Industry Insights

3.1. Industry segmentation

3.2. Industry size and forecast, 2013 – 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Rising number of pets’ population

3.3.1.2.    Increasing prevalence of cancer in pets

3.3.1.3.    Rising willingness of pet owners to spend on pet healthcare

3.3.1.4.    Increasing number of new product development

3.3.2. Industry pitfalls & challenges

3.3.2.1. Side-effects of Pet cancer therapeutics

3.3.2.2.    Dearth of veterinary oncologist

3.3.2.3.    Low out of pocket expenditure on pet healthcare in developing countries

3.4. Regulatory landscape

3.4.1. U.S.

3.4.2. Europe

3.5. Technology landscape

For More Info: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Web site: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog/

Inhalation Anesthesia Market: Global Industry Analysis, Size, Share, and Forecasts 2017–2024

Posted on Updated on

This global Inhalation Anesthesia market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.

Inhalation Anesthesia Market is set to exceed USD 1.6 billion by 2024; according to a new research report. An inhalational anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation. They are administered by anaesthetists (a term which includes anaesthesiologists, nurse anaesthetists, and anaesthesiologist assistants) through an anaesthesia mask, laryngeal mask airway or tracheal tube connected to an anaesthetic vaporiser and an anaesthetic delivery system. Agents of significant contemporary clinical interest include volatile anaesthetic agents such as isoflurane, sevoflurane and desflurane, as well as certain anaesthetic gases such as nitrous oxide and xenon.

Rising number of geriatric population coupled with increasing number of chronic diseases such as cancer, cardiovascular, neurological, and respiratory disorders and introduction of advanced anesthesia will offer lucrative growth opportunities for the inhalation anesthesia market growth.

Increasing number of emergency surgeries driving the count of hospital admissions coupled with favorable private and public insurance will drive the inhalation anesthesia market. Growing investment in healthcare infrastructure development in emerging economies and increasing adoption of universal health coverage resulting in demand among public as well as private healthcare setups will propel the business growth.

Increasing number of surgeries performed in ambulatory surgical centers will stimulate business growth over the forecast years. Growing adoption of inhalation anesthesia for globally rising prevalence of cataract surgeries, enhanced access to healthcare treatments, and rise in disposable income will fuel the industry growth.

Adverse side effects during recovery, procedure or surgery, or wearing off anesthesia coupled with effect like intraoperative discomfort, hypotension, post-lumbar-puncture headache, and potential for neurologic and cardiac toxicity from anesthetics may hamper the inhalation anesthesia market growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467773/

Germany accounted for highest revenue share in the region, owing to increasing chronic conditions associated with elderly population coupled with adoption rate of inhalation anesthesia. Growing prevalence of cancers and cardiovascular disorders accounting for approximately 66% of overall deaths in Germany will drive the industry growth over the forecast years.

China will grow at a significant rate owing to its growing research studies in the business and high prevalence of lung cancer occurred due to pollution. Increasing use of sevoflurane and desflurane in general anesthesia pertaining to superiority of awakening afterwards surgical procedure as compared to traditional inhaled anesthetics will drive the industry growth in the country. Presence of organizations and associations offering platform for research and findings for anesthesia and mounting occurrence of chronic conditions will fuel the business growth in India.

Brazil is projected to grow at a substantial rate over the forecast period. Increasing prevalence of chronic conditions coupled with high adoption of inhalation anesthesia technique as compared to intravenous anesthesia (AVT) will stimulate business expansion in the country.

Some of the companies operating in market are Abbott, Baxter International, Piramal, Lunan Pharmaceutical, Hikma Pharmaceuticals and Halocarbon Products. Introduction of novel product and growing focus on geographical expansion will propel the industry growth. Key industry players will endeavor to reinforce their position in this competitive market by implementing these strategies.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467773/

Table of Content:

Chapter 1.    Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical modeling and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition

1.1.5. Market definition and forecast assumptions

1.2. Data Sources

1.2.1. Primary

1.2.2. Secondary

Chapter 2.    Executive Summary

2.1. Inhalation anesthesia industry 360 degree synopsis, 2013 – 2024

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Application trends

2.1.4. Regional trends

Chapter 3.    Inhalation Anesthesia Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increasing incidence of chronic diseases CVS, respiratory, cancer

3.3.1.2. Growing geriatric population

3.3.1.3. Increased number of surgeries performed in ambulatory surgical centers

3.3.2. Industry pitfalls & challenges

3.3.2.1. Adverse effects of anesthesia

3.4. Growth potential analysis

3.4.1. By Product

3.4.2. By Application

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Reimbursement scenario

3.6.1. U.S

3.6.2. Europe

3.7. Porter’s analysis

For More Info: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Web site: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog/

Global Antidiabetics Market Forecast Showing 10.5% CAGR to 2024

Posted on

The 2017-2024 report on global Antidiabetics market explores the essential factors of Antidiabetics industry covering current scenario, market demand information, coverage of active companies and segmentation forecasts.

Antidiabetics Market is set to reach USD 110 billion by 2024; according to a new research report. Drugs used in diabetes treat diabetes mellitus by lowering glucose levels in the blood. With the exceptions of Insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral antihyperglycemic agents. There are different classes of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, as well as other factors.

Increasing number of obese and diabetic patients coupled with rising patient awareness levels serve as high impact rendering factors for antidiabetic market growth over the forecast period.

Rising geriatric population base, innovation of new drugs, increasing adoption of drugs and increased disposable income should further drive industry growth. Owing to the changes in lifestyle, even children between age group of 13-14 years are at high risk to get diabetes. It offers huge opportunities industry players.

Favorable government initiatives such as Diabetes Prevention Program (DPP) that aims to help individuals with prediabetes, reduces their risk to develop type 2 diabetes. Trained lifestyle coach works with participants and communicate lifestyle skills, such as, eating healthy food, physical activity and managing stress. Such initiatives should propel industry growth over the forecast period.

Advent of new technologies in products like long acting insulin analogs as well as rapid acting with increased effectiveness should drive industry growth over the forecast timeframe. The novel insulin pen technology permits low-pain and suitable daily insulin injection that should upsurge therapy sales. Type 2 diabetes mellitus (T2DM) has strong familial aggregation, the person with a parent or sibling with disease are at high risk. People with obesity, hypertension, or dyslipidemia and women with history of gestational diabetes are also at high risk to develop T2DM.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467744/

U.S. antidiabetics market valued over USD 19.4 billion in 2016 and expected to grow significantly over the coming years. Increased healthcare expenditure along with availability of improved healthcare infrastructure and favorable reimbursement policies should drive antidiabetics market .

UK contributed for significant revenue share in 2016. The growth is attributed due to wide range of funds offered by Diabetes UK for research related to the treatment of diabetes and its complications. In November 2016, the Prime Minister introduced new Diabetes UK office on World Diabetes Day.

Japan antidiabetics market should grow at significant rate over the forecast period. Diabetic population is on rise due to lifestyle changes that will accompany economic growth and drive antidiabetic market growth. The Japan Diabetes Society (JDS) encourage progress and development of diabetes study and prevent people from disease in the country.

Brazil contributed for significant revenue share. The growth is attributed due to early adoption of insulin analogues and increased use of these products in the country.

Some of the companies operating in antidiabetics market include Eli Lilly, Pfizer, Novo Nordisk, Takeda Pharmaceuticals, Sanofi Aventis, Merck, Boehringer Ingelheim and Oramed Pharmaceuticals.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467744/

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.1.1.  Initial data exploration

1.1.2.  Statistical modeling and forecast

1.1.3.  Industry insights and validation

1.1.4.  Market definition and forecast parameters

1.2. Data sources

1.2.1.  Secondary

1.2.2.  Primary

Chapter 2.Executive Summary

2.1. Antidiabetics industry 360 degree synopsis, 2013 – 2024

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Application trends

2.1.4.  Regional trends

Chapter 3. Antidiabetics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact force

3.3.1.  Growth drivers

3.3.1.1.    Gradual increase in prevalence of diabetes

3.3.1.2.    Presence of strong product pipeline portfolio

3.3.1.3.    Increasing prevalence of lifestyle induced disorders such as obesity

3.3.2.  Industry pitfalls & challenges

3.3.2.1.    High insulin prices

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By application

3.5. Regulatory landscape

3.5.1.  U.S

3.5.2.  Europe

3.6. Reimbursement scenari

3.6.1.  U.S

3.6.2.  Europe

3.7. Pipeline overview

3.8. Porter’s analysis

3.9. Competitive landscape, 2016

3.9.1.  Business overview

3.9.2.  Revenue analysis

3.9.3.  Product landscape

3.9.4.  Strategy dashboard

3.10.        PESTEL analysis

Chapter 4.   Antidiabetics Market, By Product

4.1. Global antidiabetics market share, by product, 2016 & 202

4.2. Insulin

4.2.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.2.  Rapid acting analog

4.2.2.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.3.  Long acting analog

For More Info: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Web site: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog/

Over-the-Counter Drugs Market Trend to 2024 Profiling Johnson & Johnson Pfizer, Cipla, Dr. Reddy’s Laboratories, Takeda, Teva Pharmaceuticals, Sanofi, Bayer & more

Posted on Updated on

MarketStudyReport.com Adds New Over-the-Counter (OTC) Drugs Market 2017 – 2024 research report providing information and By Product, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 120 Pages with table and figures in it.

Over-the-Counter (OTC) Drugs Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 5% CAGR to 2024.

Over-the-Counter (OTC) Drugs Market is set to exceed USD 178 billion by 2024; according to a new research report. Expanding geriatric population base which is highly susceptible to suffer from several diseases such as joint pain will drive global Over-the-Counter (OTC) drugs demand over the forecast period. Growing healthcare awareness among people and cost-effectiveness associated with OTC drugs will further fuel industry growth.

Pharmaceutical companies’ switch from Rx to OTC drugs serves as high impact rendering factor on industry growth over the forecast period. This will provide potential growth opportunities for companies to rejuvenate an off-patent brand into a new life-cycle growth phase.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/744109/

Issues pertaining to substance abuse and less awareness in emerging and underdeveloped economies about medicines are major growth restraining factors. Furthermore, risk associated with taking wrong medicines due to improper self-diagnosis is most likely to make regulations more stringent.

Analgesics accounted for significant value share of the market in 2016. OTC analgesics have application in the treatment of fever, headaches, flu, colds, musculoskeletal injuries & disorders, arthritis, toothaches, and menstrual cramps which will spur demand. Frequent body pain experienced by geriatric population, increasing incidences of arthritis, cancer and cardiovascular disease, and increasing investment in R&D by public & private sector, with major focus to formulate new therapeutics and will drive industry growth.

Cold, cough and flu segment should witness substantial growth over the forecast timeframe. The growth is attributed by demand from increasing number of individuals catching cold and flu multiple times in a year. Non-life-threatening nature of these infections make OTC medication a viable choice for the patient, resulting to escalating demand. Moreover, increasing awareness through media such as TV, social media home pages and print circular will propel industry growth.

U.S. OTC drugs market witness lucrative growth over the forecast period. Increasing preference for the drugs for minor injuries along with increasing self-medication and self-care will spur demand. Moreover, rising healthcare expenditure, favorable regulatory scenario and presence of major players in the country will fuel industry growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/744109/

UK market should witness substantial growth due to increasing awareness pertaining to self-treatment medication. Increased availability of OTC medicines in country will help government to minimize the healthcare cost and provide better access to public and propel business growth over the forecast timeframe.

Some of the companies operating in OTC drugs market includes, Johnson & Johnson Pfizer, Cipla, Dr. Reddy’s Laboratories, Takeda, Teva Pharmaceuticals, Sanofi, Bayer and GlaxoSmithKline.  Industry players are focusing on new product development and acquisition strategy to gain market share.

Table of Content:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Over-the-Counter (OTC) Drugs Industry Insights

Chapter 4. Over-the-Counter (OTC) Drugs Market, By Product

Chapter 5. Over-the-Counter (OTC) Drugs Market, By Region

Chapter 6. Company Profiles

For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Related Report:

United States Over-the-Counter (OTC) Drugs Market Report 2018

In this report, the United States Over-the-Counter (OTC) Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

https://www.marketstudyreport.com/reports/united-states-over-the-counter-otc-drugs-market-report-2018/?utm_source=RR-PSR

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

Cardiovascular Disease Drugs Market Trends Global Industry Analysis, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2025

Posted on Updated on

The “Cardiovascular Disease Drugs Market” Report offers an inclusive and decision-making overview, including definitions, classifications and its applications. The Cardiovascular Disease Drugs market is anticipated to reflect a positive growth trend in forthcoming years. The essential driving forces behind the growth and popularity of Cardiovascular Disease Drugs market is analyzed detailed in this report.

Global Cardiovascular Disease Drugs Market Research Report 2018 estimates the drivers, restraints, and opportunities pertaining to the global Cardiovascular Disease Drugs market over the timeframe of 2018-2025. Delivering the key insights pertaining to this industry, the report provides an in-depth analysis of the latest trends, present and future business scenario, market size and share, and commercialization potential of the Cardiovascular Disease Drugs industry over the coming years.

Request a Free sample PDF of this research to evaluate more @ https://www.marketstudyreport.com/request-a-sample/747548//?utm_source=WPB-SP

The competitive landscape of the Cardiovascular Disease Drugs market profiles the key players participating in the global business space. These include as AstraZeneca, Johnson & Johnson, Pfizer, Sanofi, Merck, Daiichi Sankyo Company Limited, Novartis, Bayer, Takeda Pharmaceutical, Hoffmann-La Roche, United Therapeutics Corporation, Actelion Pharmaceuticals, Boehringer Ingelheim and Astellas Pharma. The report also details the market positioning, strategies, and revenue procured by each of these manufacturers.

The industry is analyzed in terms of products, applications, regions, and the key manufacturers holding a prominent share of the global revenue.

The product landscape of the Cardiovascular Disease Drugs market comprises Heparin, Coumadin, Sectral, Zebeta, Lopressor, Toprol XL, Norvasc, Lotrel and Others. The report further details the market share to be procured by each of these products over the coming years.

Enquire Discount on Global Cardiovascular Disease Drugs Market Research Report @ https://www.marketstudyreport.com/check-for-discount/747548//?utm_source=SPR-SP

In terms of end-user or applications, the report is segmented into Asischemic Heart Disease, Dyslipidemia, Stroke, Thrombosis, Atherosclerosis, Coronary Artery Diseases, Peripheral Artery Disease and Others. A detailed analysis of the contribution of these application segments to the overall market revenue and volume has been included in the report.

The regional segmentation of the report includes United States, EU, Japan, China, India and Southeast Asia. Detailing the consumption and production rate of Cardiovascular Disease Drugs in these regions, the report outlines the growth curve of this industry in terms of market volume and share over 2018-2025.

Major Points in Table of Contents:

Global Cardiovascular Disease Drugs Market Size, Status and Forecast 2025

Industry Overview of Cardiovascular Disease Drugs Market

Global Cardiovascular Disease Drugs Market Competition Analysis by Players

Global Cardiovascular Disease Drugs Market Company (Top Players) Profiles

Global Cardiovascular Disease Drugs Market Size by Type and Application (2013-2018)

United States Cardiovascular Disease Drugs Market Development Status and Outlook

EU Cardiovascular Disease Drugs Market Development Status and Outlook

Japan Cardiovascular Disease Drugs Industry Development Status and Outlook

China Cardiovascular Disease Drugs Market Development Status and Outlook

India Cardiovascular Disease Drugs Industry Development Status and Outlook

Southeast Asia Cardiovascular Disease Drugs Industry Development Status and Outlook

Market Forecast by Regions, Type and Application (2018-2025)

Cardiovascular Disease Drugs Industry Dynamics

Market Effect Factors Analysis

Research Findings and Conclusion

Related Reports: –

2017 Global and Regional Cardiovascular Disease Diagnostic Equipment Market Research Report Forecasts 2022

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc.

https://www.marketstudyreport.com/reports/2017-global-and-regional-cardiovascular-disease-diagnostic-equipment-market-research-report-forecasts-2022/?utm_source=RR-SP

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

The Green Suite #4594,

Dover, DE 19901

United States

Phone: 1-201-355-0868

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

News: https://www.marketstudyreport.com/category/news-releases/

Connect with us: Google+ | LinkedIn | Twitter